The global market for Latex Particle for In-Vitro Diagnostics was valued at US$ 49.6 million in the year 2023 and is projected to reach a revised size of US$ 70.3 million by 2030, growing at a CAGR of 5.5% during the forecast period.
Latex particles, also known as latex microspheres, are small, spherical beads made from synthetic latex polymers (usually polystyrene) that are typically used in a variety of in-vitro diagnostic (IVD) applications. These particles are widely employed due to their high surface area, uniform size, ease of functionalization, and ability to carry various reagents or biomolecules (e.g., antibodies, antigens, nucleic acids) for detecting specific analytes in biological samples.
Latex particles are utilized in diagnostic assays to enhance the detection and quantification of target molecules (such as proteins, DNA, viruses, etc.) in a sample. The interaction between the latex particles and the target analyte produces a measurable signal, often in the form of a color change or fluorescence.
Market Size and Growth
The global in-vitro diagnostics (IVD) market, including latex particles, is expected to grow steadily, driven by an increasing demand for point-of-care testing, disease diagnostics, and home care kits.
Technological Developments
Advances in automation for both latex particle production and the diagnostic processes (such as in high-throughput screening) are driving the adoption of latex-based tests, particularly in clinical labs and high-volume testing environments.
Competitive Landscape
The market for latex particles in diagnostics is highly competitive, with several large multinational companies dominating the market. However, there is also significant competition from specialized companies offering more tailored and niche solutions.
Aging Population
The aging global population is leading to an increase in age-related diseases such as Alzheimer鈥檚, diabetes, and cancer. As the elderly population grows, the demand for effective diagnostic solutions, including those based on latex particles, will continue to rise.
Market Fragmentation
The market for latex particles is fragmented, with different companies focusing on different types of latex products or diagnostic applications. This fragmentation can make it difficult for companies to establish dominant market positions or create large-scale economies.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Latex Particle for In-Vitro Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Latex Particle for In-Vitro Diagnostics.
The Latex Particle for In-Vitro Diagnostics market size, estimations, and forecasts are provided in terms of output/shipments (L) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Latex Particle for In-Vitro Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Latex Particle for In-Vitro Diagnostics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
JSR Life Sciences
Merck
Bangs Laboratories
Thermo Fisher
Agilent
IKERLAT Polymers
Fujikura Kasei
CD Bioparticles
VDO Biotech
Suzhou NanoMicro
Sunresin New Materials
by Type
Plain Latex Particles
Carboxy-Modified Latex Particles
Other
by Application
Latex Immunoturbidimetry
Latex Agglutination Test
Immunochromatography
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Latex Particle for In-Vitro Diagnostics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Latex Particle for In-Vitro Diagnostics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Latex Particle for In-Vitro Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Latex Particle for In-Vitro Diagnostics Market Overview
1.1 Product Definition
1.2 Latex Particle for In-Vitro Diagnostics by Type
1.2.1 Global Latex Particle for In-Vitro Diagnostics Market Value Growth Rate Analysis by Type: 2023 VS 2030
1.2.2 Plain Latex Particles
1.2.3 Carboxy-Modified Latex Particles
1.2.4 Other
1.3 Latex Particle for In-Vitro Diagnostics by Application
1.3.1 Global Latex Particle for In-Vitro Diagnostics Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Latex Immunoturbidimetry
1.3.3 Latex Agglutination Test
1.3.4 Immunochromatography
1.3.5 Other
1.4 Global Market Growth Prospects
1.4.1 Global Latex Particle for In-Vitro Diagnostics Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Latex Particle for In-Vitro Diagnostics Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Latex Particle for In-Vitro Diagnostics Production Estimates and Forecasts (2019-2030)
1.4.4 Global Latex Particle for In-Vitro Diagnostics Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Latex Particle for In-Vitro Diagnostics Production Market Share by Manufacturers (2019-2024)
2.2 Global Latex Particle for In-Vitro Diagnostics Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Latex Particle for In-Vitro Diagnostics, Industry Ranking, 2022 VS 2023
2.4 Global Latex Particle for In-Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Latex Particle for In-Vitro Diagnostics Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Latex Particle for In-Vitro Diagnostics, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Latex Particle for In-Vitro Diagnostics, Product Offered and Application
2.8 Global Key Manufacturers of Latex Particle for In-Vitro Diagnostics, Date of Enter into This Industry
2.9 Latex Particle for In-Vitro Diagnostics Market Competitive Situation and Trends
2.9.1 Latex Particle for In-Vitro Diagnostics Market Concentration Rate
2.9.2 Global 5 and 10 Largest Latex Particle for In-Vitro Diagnostics Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Latex Particle for In-Vitro Diagnostics Production by Region
3.1 Global Latex Particle for In-Vitro Diagnostics Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Latex Particle for In-Vitro Diagnostics Production Value by Region (2019-2030)
3.2.1 Global Latex Particle for In-Vitro Diagnostics Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Latex Particle for In-Vitro Diagnostics by Region (2025-2030)
3.3 Global Latex Particle for In-Vitro Diagnostics Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Latex Particle for In-Vitro Diagnostics Production by Region (2019-2030)
3.4.1 Global Latex Particle for In-Vitro Diagnostics Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Latex Particle for In-Vitro Diagnostics by Region (2025-2030)
3.5 Global Latex Particle for In-Vitro Diagnostics Market Price Analysis by Region (2019-2024)
3.6 Global Latex Particle for In-Vitro Diagnostics Production and Value, Year-over-Year Growth
3.6.1 North America Latex Particle for In-Vitro Diagnostics Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Latex Particle for In-Vitro Diagnostics Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Latex Particle for In-Vitro Diagnostics Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Latex Particle for In-Vitro Diagnostics Production Value Estimates and Forecasts (2019-2030)
4 Latex Particle for In-Vitro Diagnostics Consumption by Region
4.1 Global Latex Particle for In-Vitro Diagnostics Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Latex Particle for In-Vitro Diagnostics Consumption by Region (2019-2030)
4.2.1 Global Latex Particle for In-Vitro Diagnostics Consumption by Region (2019-2030)
4.2.2 Global Latex Particle for In-Vitro Diagnostics Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Latex Particle for In-Vitro Diagnostics Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Latex Particle for In-Vitro Diagnostics Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Latex Particle for In-Vitro Diagnostics Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Latex Particle for In-Vitro Diagnostics Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Latex Particle for In-Vitro Diagnostics Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Latex Particle for In-Vitro Diagnostics Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Latex Particle for In-Vitro Diagnostics Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Latex Particle for In-Vitro Diagnostics Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Latex Particle for In-Vitro Diagnostics Production by Type (2019-2030)
5.1.1 Global Latex Particle for In-Vitro Diagnostics Production by Type (2019-2024)
5.1.2 Global Latex Particle for In-Vitro Diagnostics Production by Type (2025-2030)
5.1.3 Global Latex Particle for In-Vitro Diagnostics Production Market Share by Type (2019-2030)
5.2 Global Latex Particle for In-Vitro Diagnostics Production Value by Type (2019-2030)
5.2.1 Global Latex Particle for In-Vitro Diagnostics Production Value by Type (2019-2024)
5.2.2 Global Latex Particle for In-Vitro Diagnostics Production Value by Type (2025-2030)
5.2.3 Global Latex Particle for In-Vitro Diagnostics Production Value Market Share by Type (2019-2030)
5.3 Global Latex Particle for In-Vitro Diagnostics Price by Type (2019-2030)
6 Segment by Application
6.1 Global Latex Particle for In-Vitro Diagnostics Production by Application (2019-2030)
6.1.1 Global Latex Particle for In-Vitro Diagnostics Production by Application (2019-2024)
6.1.2 Global Latex Particle for In-Vitro Diagnostics Production by Application (2025-2030)
6.1.3 Global Latex Particle for In-Vitro Diagnostics Production Market Share by Application (2019-2030)
6.2 Global Latex Particle for In-Vitro Diagnostics Production Value by Application (2019-2030)
6.2.1 Global Latex Particle for In-Vitro Diagnostics Production Value by Application (2019-2024)
6.2.2 Global Latex Particle for In-Vitro Diagnostics Production Value by Application (2025-2030)
6.2.3 Global Latex Particle for In-Vitro Diagnostics Production Value Market Share by Application (2019-2030)
6.3 Global Latex Particle for In-Vitro Diagnostics Price by Application (2019-2030)
7 Key Companies Profiled
7.1 JSR Life Sciences
7.1.1 JSR Life Sciences Latex Particle for In-Vitro Diagnostics Company Information
7.1.2 JSR Life Sciences Latex Particle for In-Vitro Diagnostics Product Portfolio
7.1.3 JSR Life Sciences Latex Particle for In-Vitro Diagnostics Production, Value, Price and Gross Margin (2019-2024)
7.1.4 JSR Life Sciences Main Business and Markets Served
7.1.5 JSR Life Sciences Recent Developments/Updates
7.2 Merck
7.2.1 Merck Latex Particle for In-Vitro Diagnostics Company Information
7.2.2 Merck Latex Particle for In-Vitro Diagnostics Product Portfolio
7.2.3 Merck Latex Particle for In-Vitro Diagnostics Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Merck Main Business and Markets Served
7.2.5 Merck Recent Developments/Updates
7.3 Bangs Laboratories
7.3.1 Bangs Laboratories Latex Particle for In-Vitro Diagnostics Company Information
7.3.2 Bangs Laboratories Latex Particle for In-Vitro Diagnostics Product Portfolio
7.3.3 Bangs Laboratories Latex Particle for In-Vitro Diagnostics Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Bangs Laboratories Main Business and Markets Served
7.3.5 Bangs Laboratories Recent Developments/Updates
7.4 Thermo Fisher
7.4.1 Thermo Fisher Latex Particle for In-Vitro Diagnostics Company Information
7.4.2 Thermo Fisher Latex Particle for In-Vitro Diagnostics Product Portfolio
7.4.3 Thermo Fisher Latex Particle for In-Vitro Diagnostics Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Thermo Fisher Main Business and Markets Served
7.4.5 Thermo Fisher Recent Developments/Updates
7.5 Agilent
7.5.1 Agilent Latex Particle for In-Vitro Diagnostics Company Information
7.5.2 Agilent Latex Particle for In-Vitro Diagnostics Product Portfolio
7.5.3 Agilent Latex Particle for In-Vitro Diagnostics Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Agilent Main Business and Markets Served
7.5.5 Agilent Recent Developments/Updates
7.6 IKERLAT Polymers
7.6.1 IKERLAT Polymers Latex Particle for In-Vitro Diagnostics Company Information
7.6.2 IKERLAT Polymers Latex Particle for In-Vitro Diagnostics Product Portfolio
7.6.3 IKERLAT Polymers Latex Particle for In-Vitro Diagnostics Production, Value, Price and Gross Margin (2019-2024)
7.6.4 IKERLAT Polymers Main Business and Markets Served
7.6.5 IKERLAT Polymers Recent Developments/Updates
7.7 Fujikura Kasei
7.7.1 Fujikura Kasei Latex Particle for In-Vitro Diagnostics Company Information
7.7.2 Fujikura Kasei Latex Particle for In-Vitro Diagnostics Product Portfolio
7.7.3 Fujikura Kasei Latex Particle for In-Vitro Diagnostics Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Fujikura Kasei Main Business and Markets Served
7.7.5 Fujikura Kasei Recent Developments/Updates
7.8 CD Bioparticles
7.8.1 CD Bioparticles Latex Particle for In-Vitro Diagnostics Company Information
7.8.2 CD Bioparticles Latex Particle for In-Vitro Diagnostics Product Portfolio
7.8.3 CD Bioparticles Latex Particle for In-Vitro Diagnostics Production, Value, Price and Gross Margin (2019-2024)
7.8.4 CD Bioparticles Main Business and Markets Served
7.8.5 CD Bioparticles Recent Developments/Updates
7.9 VDO Biotech
7.9.1 VDO Biotech Latex Particle for In-Vitro Diagnostics Company Information
7.9.2 VDO Biotech Latex Particle for In-Vitro Diagnostics Product Portfolio
7.9.3 VDO Biotech Latex Particle for In-Vitro Diagnostics Production, Value, Price and Gross Margin (2019-2024)
7.9.4 VDO Biotech Main Business and Markets Served
7.9.5 VDO Biotech Recent Developments/Updates
7.10 Suzhou NanoMicro
7.10.1 Suzhou NanoMicro Latex Particle for In-Vitro Diagnostics Company Information
7.10.2 Suzhou NanoMicro Latex Particle for In-Vitro Diagnostics Product Portfolio
7.10.3 Suzhou NanoMicro Latex Particle for In-Vitro Diagnostics Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Suzhou NanoMicro Main Business and Markets Served
7.10.5 Suzhou NanoMicro Recent Developments/Updates
7.11 Sunresin New Materials
7.11.1 Sunresin New Materials Latex Particle for In-Vitro Diagnostics Company Information
7.11.2 Sunresin New Materials Latex Particle for In-Vitro Diagnostics Product Portfolio
7.11.3 Sunresin New Materials Latex Particle for In-Vitro Diagnostics Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Sunresin New Materials Main Business and Markets Served
7.11.5 Sunresin New Materials Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Latex Particle for In-Vitro Diagnostics Industry Chain Analysis
8.2 Latex Particle for In-Vitro Diagnostics Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Latex Particle for In-Vitro Diagnostics Production Mode & Process
8.4 Latex Particle for In-Vitro Diagnostics Sales and Marketing
8.4.1 Latex Particle for In-Vitro Diagnostics Sales Channels
8.4.2 Latex Particle for In-Vitro Diagnostics Distributors
8.5 Latex Particle for In-Vitro Diagnostics Customers
9 Latex Particle for In-Vitro Diagnostics Market Dynamics
9.1 Latex Particle for In-Vitro Diagnostics Industry Trends
9.2 Latex Particle for In-Vitro Diagnostics Market Drivers
9.3 Latex Particle for In-Vitro Diagnostics Market Challenges
9.4 Latex Particle for In-Vitro Diagnostics Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
JSR Life Sciences
Merck
Bangs Laboratories
Thermo Fisher
Agilent
IKERLAT Polymers
Fujikura Kasei
CD Bioparticles
VDO Biotech
Suzhou NanoMicro
Sunresin New Materials
听
听
*If Applicable.
